Frequently Asked Questions for the Illuminating the Druggable Genome Implementation Phase

We appreciate your interest in the Illuminating the Druggable Genome Program Request for Application (RFA-RM-21-012) and hope that you and your team will choose to submit an application. In order to maximize your chances of success, we would like to provide some guidance that may be helpful as you put the finishing touches on your application

 

 

 

This page last reviewed on April 5, 2021